America's Seniors at www.TodaysSeniorsNetwork.com
 
AddThis Feed ButtonNow, keep up to date with daily feeds of newly posted stories about America's Seniors...click on the box to the left
Election 2008...New! MSNBC Dashboard with continuous updates...information...stats...click here
 

 

 

 

 

 

Home
Up
Baseball Fights Skin Cancer
Detect Melanoma Early
Distance & Thickness
Fewer Facial Scars
Free Tests
Hidden Melanomas
How Melanomas Look
Indoor Dangers
Inherited Melanoma
Melanoma Risks Increase
Melanoma Vaccine
Mylenoma Therapy
Melanoma Increases
Metastastic Melanoma
Most Deadly Melanomas
Multiple Mylenoma Treatment
New Melanoma Treatment
New Treatments
Patient's T Cells Work
Sarcoma Differences
Skin Cancer Epidemic
Skin Protection Tips
Sun Protection
Sunscreen Tips
Thick Melanomas
Transplants, Skin Cancer
Updated Resources
Women Skin Cancer Up

Home
African-American Tests
Age No Barrier
Aging and Cancer
Alcohol Cancer Risk
Alcohol,Smoking Link
Anemia Drug Dangerous
Armstrong Support
Aspirin Helps
Aspirin,Prostate
Asthma-Cancer Link
Attacking Brain Cancer
Avoid Thin,Fat
Awareness Issues
Blacks, Cancer
Bladder Cancer
Body Composition
Bogus 'Cures'
Benefit Disputed
Boston Cancer Suvivors
Brain Tumor Relief
Breast Cancer
Cancer Related Fatigue
Calls Increase Awareness
Cancer Case Explosion
Cancer Deaths Decline
Cancer, Heart Statement
Cancer Link
Cancer Infection?
Cancer Policy
Cancer Report
Cancer Risk
Cancer Risk Continues for Women
Cancer Spread
Cancer Survivors
Carolina Cancer Initative
Cartilage No Value
Cervical Cancer
Cervical Cancer Test
Colon Cancer
Community Approach to Treatment
Difficult Cancer Therapy
Detect Lung Cancer
Earlier Cancer Notification
Exercise Reduces Risk
Evaluating Cancer Therapies
Family Awareness
Family Ties
Fewer Biopsies
Fewer Deaths
Firefighters Bladder Cancer
Gains Threatened
Genetic Testing Link
Gilda's 25th Anniversary
Ginger Fights Cancer
GOLF Magazine Push
Green Tea Helps
Group Therapy Questioned
Head and Neck Cancer
Immigrant Cancer History
Immune Deterrent
Ineffective Drug
Inherited Cancer Risk
Lack of Attention
Lifestyle Changes Benefit
Lung Cancer
Lymphoma Survival Rates
Make Informed Choices
Mammogram Use
Managing Nausea
Men, Bladder Cancer
Minority Awareness
Minority Cancer Awareness
Minority Grants
Minorities, Cancer
More Involvement
MRI for Brain Tumors
Neck, Head Cancer
New Detection Method
New Ginkgo Use
Nurses Halt Chemo
Non-Invasive Detection
Obesity and Cancer
Obesity, Cancer Link
Off-Label Stent Study
Older Women, Breast Cancer
One-Step Radiation
Ovarian Cancer News
Oral Cancer Detection
Ovarian Cancer Awareness
Passive Smoke Risk
Pelvic Fracture Risk
Poverty Link
Preventing Cancer
Preventing Recurrence
Prevention Tips
New Metastatic Treatment
New Treatment Initiative
Progress Report: Cancer 2007
Prostate Cancer News
Racial Treament Differs
Rally Cancer Awareness
Relief from Sea Possible
Screening Benefit
Self-Fulfilling Prophecy
Skin Cancer News
Smelling Cancer?
Smoking Hurts Recovery
Soy Helps
Stomp Out Cancer
Stopping Metastasis
Stop Stomach Cancer
Stress & Cancer
Stress, Cervical Cancer
Surgery Best Option
Surgery Delay Deadly
Surviviors' Music
Survival Priority
Survivor Depression
Take Part in Program
Tea Helps Skin
Theismann on Prostate
Spouses Impacted
Standup2Cancer
Tips in Recovery
Tongue Cancer
Treat Bladder Cancer
Treatment Differences
Treatment Risk
Trials Started
Tumors Can't Hide
Unsubstantiated Claims
Watchful Waiting
Wine Cuts Risk
Women's Awareness
Women at Risk
Women, Lung Cancer
Yul Brynner Foundation
Zinc Role
2008 Cancer Awareness

Copyright (c) 
America's Seniors/
TodaysSeniorsNetwork.com

Contact us at
America's Seniors/ 
TodaysSeniorsNetwork.com

 

Google
 

 

Web TodaysSeniorsNetwork.com

 

Melanoma vaccine strategy shows promise in laboratory experiments

Newswise — A novel approach to creating a vaccine to treat melanoma has demonstrated promising effectiveness in a new laboratory study led by researchers at The Wistar Institute. About a third of melanoma patients might benefit from such a vaccine. The study appears in the current issue of Cancer Research.

In the study, the scientists used a small protein called a peptide found in approximately 70 percent of melanomas, but not in normal cells, to stimulate immune cells called killer T cells to attack the melanoma cells. Another type of immune cell called a monocyte was used to present the peptide, BRAFV600E, to the killer T cells to trigger their attack on the melanoma cells.

“In our experiments, we saw a strong cancer-killing immune response when killer T cells are stimulated with this peptide,” says Dorothee Herlyn, D.V.M., senior author on the study and a professor in the Immunology Program and Molecular and Cellular Oncogenesis Program at Wistar. “The results emphasize the potential of this approach for creating an effective melanoma vaccine, and we hope to move toward human clinical trials as soon as possible.”

A substantial proportion of melanoma patients, about 50 percent, have killer T cells able to recognize the BRAFV600E peptide. Combining the prevalence of the peptide among melanoma patients – about 70 percent – with the number of patients whose immune cells are able to respond to the peptide suggests that a vaccine based on BRAFV600E could treat approximately a third of all melanoma patients.

Herlyn adds that the specificity of the peptide – the fact that it is found only in melanoma cells, not normal cells – suggests that the toxicity of any vaccine based on the peptide would be minimal. Killer T cells sparked into action by the vaccine would target only the cancer cells, sparing healthy cells entirely.

Looking ahead to possible human clinical trials, another member of the scientific team, University of Pennsylvania assistant professor Brian Czerniecki, M.D., Ph.D., is working to prepare yet another type of immune cell, called a dendritic cell, to present the BRAFV600E peptide to killer T cells. Dendritic cells have as their primary job the presentation of foreign materials to the immune system, and the expectation is that dendritic cells presenting the BRAFV600E peptide would trigger the killer T cells even more effectively than the monocyte cells used in the current study. Indeed, such prepared dendritic cells might serve as the basis for a treatment vaccine that could be taken into human clinical trials.

Herlyn is senior author on the Cancer Research study. The lead author is Rajasekharan Somasundaram, also at Wistar. The additional Wistar coauthors are Rolf Swoboda, Laura Caputo, and Laszlo Otvos (now at Temple University). The remaining coauthors are Barbara Weber, Patricia Volpe, Patricia van Belle, Susan Hotz, David E. Elder, Lynn Schuchter, DuPont Guerry, and Brian J. Czerniecki of the University of Pennsylvania, and Francesco M. Marincola with the National Institutes of Health.

Support for the research was provided by the National Institutes of Health and the Commonwealth Universal Research Enhancement Program of the Pennsylvania Department of Health.

The Wistar Institute is an independent nonprofit biomedical research institution dedicated to discovering the causes and cures for major diseases, including cancer, cardiovascular disease, autoimmune disorders, and infectious diseases, including AIDS and influenza. Founded in 1892 as the first institution of its kind in the nation, The Wistar Institute today is a National Cancer Institute-designated Cancer Center focused on basic and translational research. Discoveries at Wistar have led to the creation of vaccines for such diseases as rabies, rubella, and rotavirus; significant insights into the mechanisms of skin, brain, breast, lung, and prostate cancers; and the development of monoclonal antibodies and other significant research technologies and tools. News releases from The Wistar Institute are available to reporters by direct e-mail upon request.

 

Home
Up
About Us
America's Seniors WebMall
Aging News
California Report
Caregiving
Community/Workplace
Fitness,Health
Election 2008
Grandparents
Health Care Policy
Hispanic Seniors
Medicare News
Contents/Sitemap
Prescription Drugs
Pharma Suits
Restaurant Reviews
Rural Seniors
Safety & Security
Growing New Parts
Seniors Commentary
Seniors' Entertainment
Seniors Headlines
Seniors Finances
Seniors' Issues
Seniors Relationships
Seniors Rights
Social Security News
The Virtual Family
Total Care Pharmacy
Travel News
TSN Radio on Web
Veterans' Tribute
White House Cards
Privacy Policy
Sitemap Contents
Consumer Alert

 

 

Copyright 1999-2008 TodaysSeniorsNetwork.com
To Contact Us, Click Here